Search results
Silence Therapeutics (SLN) Moves 5.8% Higher: Will This Strength Last?
Zacks via Yahoo Singapore Finance· 1 week agoSilence Therapeutics (SLN) witnessed a jump in share price last session on above-average trading...
FDA Accepts Ionis' (IONS) NDA for Rare Disease Drug Olezarsen
Zacks via Yahoo Singapore Finance· 3 weeks agoThe FDA grants priority review to Ionis' (IONS) filing seeking approval for olezarsen to treat...
Biotech Stock Roundup: GSK's Litigation Update, BIIB's Drug Approval & Other Updates
Zacks via Yahoo Singapore Finance· 1 month agoIt was a busy week for the biotech sector, with numerous data presentations by biotech companies at...
Ionis Pharmaceuticals (IONS) Down 0.7% Since Last Earnings Report: Can It Rebound?
Zacks via Yahoo Singapore Finance· 1 month agoIt has been about a month since the last earnings report for Ionis Pharmaceuticals (IONS). Shares...
Viking (VKTX) Falls 10% Despite Upbeat NASH Study Results
Zacks via Yahoo Singapore Finance· 1 month agoViking Therapeutics (VKTX) reports promising 52-week treatment data from a mid-stage study on its...
Shareholders Will Probably Not Have Any Issues With Ionis Pharmaceuticals, Inc.'s (NASDAQ:IONS) CEO...
Simply Wall St. via Yahoo Singapore Finance· 2 months agoKey Insights Ionis Pharmaceuticals' Annual General Meeting to take place on 6th of June Salary of...
Europe Approves Biogen's Tofersen For Adult Patients With Rare Type Of Neurodegenerative Disorder
Benzinga via Yahoo Singapore Finance· 2 months agoOn Thursday, the European Commission granted marketing authorization under exceptional circumstances...
Biogen (BIIB) Gets EU Approval for Rare Disease Drug Qalsody
Zacks via Yahoo Singapore Finance· 2 months agoBiogen BIIB announced that the European Commission (EC) has granted marketing approval to Qalsody...
The Zacks Analyst Blog Highlights Biogen, Ionis Pharmaceuticals, GSK, PTC Therapeutics and Larimar...
Zacks via Yahoo Singapore Finance· 2 months agoFor Immediate Release Chicago, IL – May 24, 2024 – Zacks.com announces the list of stocks featured...
REFILE-UPDATE 2-Biogen, Ionis to discontinue development of experimental ALS drug
Reuters via Yahoo Singapore Finance· 2 months agoBiogen and Ionis Pharmaceuticals said on Thursday they will terminate the development of their experimental treatment for amyotrophic lateral sclerosis (ALS) after failing to show improvement ...